PORT for Health: Oncology

PORT for Health: Oncology 2026 | May 28-29, 2026 | Wroclaw (POL)

Mabion will participate in the scientific conference PORT for Health: Oncology 2026, organized by Łukasiewicz – PORT. The conference will take place at the historic campus in Pracze Odrzańskie, Wrocław. Modern science will be discussed against the backdrop of red-brick industrial buildings. The conference will bring together experts in cancer biology, neuroscience, and oncology therapies to discuss the latest scientific and technological advances shaping the future of cancer treatment.

We are proud to announce that Jakub Knurek will represent Mabion with a presentation entitled “Development of Biological Drugs for Oncological Indications at Mabion”. The presentation will take place on May 29 at 3:10 PM at the Polish Center for Technology Development. It will conclude the conference agenda.

During his lecture, Jakub Knurek will present Mabion’s capabilities in the development and manufacturing of biologic drug candidates for oncology applications. Participation in PORT for Health reflects Mabion’s ongoing commitment to advancing innovative biologics. Through scientific collaboration and manufacturing expertise, we contribute to the development of modern oncology therapies.

PORT for Health: Oncology Scientific Program

The scientific program of PORT for Health reflects important directions currently shaping oncology research and biologics development. The agenda places strong emphasis on immunooncology, advanced therapeutic modalities, and the role of the tumor microenvironment in therapeutic response. A significant part of the conference is dedicated to bridging early scientific discovery with clinically and manufacturably viable therapeutic solutions. This reflects the need for closer integration of research and manufacturing to support more efficient development of oncology drug candidates. From discovery through clinical application.

We encourage conference participants to attend the presentation and connect with Jakub Knurek during the event. Jakub will be happy to discuss potential collaboration opportunities and current challenges in oncology biologics development.

Find out more information on the conference website.